Surviving Rectal Cancer at the Cost of a Colostomy International Validation of the Colostomy Impact Score
1 other identifier
observational
3,750
1 country
1
Brief Summary
The formation of a colostomy following surgery for rectal cancer changes body image, challenges patient practical skills and threatens quality of life. As the oncological results have improved over the last decades the number of survivors from rectal cancer who have to adjust to a cancer free life in their own homes is increasing. To enable the identification of the patients with stoma-related reduced health-related Quality of life (HRQoL) in a quick and reliable way we recently developed the Colostomy Impact Score (CI-score) comprising 7 items of stoma related factors with significant impact on HRQoL. The purpose of the present project is to perform an international validation of the CI-score and to demonstrate its applicability. The construct validity of the CI-score will be studied internationally on crosssectional cohorts of patients with permanent colostomy after abdominoperineal excision (APE) or Hartmann's procedure in Denmark, Sweden, Spain, the Netherlands, United Kingdom, Turkey, Brazil, Egypt, Russia, Lithuania, Israel, Portugal, South Africa, Australia and China. This will be done by testing the CI-score against five anchor questions stoma impact on HRQoL, the 5 Level version og the EuroQol measuer (EQ-5D-5L) and version 3.0 of the Quality of Life Questionnaire from the European Organisation for Research and Treatment of Cancer (EORTC QLQ C30 questionnaire v3.0). The impact of the challenges related to having a stoma may vary with different demographic, socioeconomic and cultural factors. Supplementary data on stoma care, demographics and socioeconomic status will be gathered to study the impact of patient-related factors and cultural differences on HRQoL in rectal cancer survivors with an ostomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2018
CompletedFirst Posted
Study publicly available on registry
May 7, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedNovember 17, 2020
November 1, 2020
10 months
April 24, 2018
November 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Validity of the Colostomy Impact Score
Description of sensitivity, specificity and construct validity (hypothesis testing) of the Colostomy Impact Score.
The end of 2018
Impact of demographic, socioeconomic and religious factors on HRQoL in rectal cancer survivors with a colostomy
Comparing HRQoL between sexes, age groups and different socioeconomic and religious groups and by country.
The end of 2018
Study Arms (15)
Australia
Patients with a permanent colostomy after curative surgery for rectal cancer
Brazil
Patients with a permanent colostomy after curative surgery for rectal cancer
China
Patients with a permanent colostomy after curative surgery for rectal cancer
Denmark
Patients with a permanent colostomy after curative surgery for rectal cancer
Egypt
Patients with a permanent colostomy after curative surgery for rectal cancer
Israel
Patients with a permanent colostomy after curative surgery for rectal cancer
Lithuania
Patients with a permanent colostomy after curative surgery for rectal cancer
the Netherlands
Patients with a permanent colostomy after curative surgery for rectal cancer
Portugal
Patients with a permanent colostomy after curative surgery for rectal cancer
Russia
Patients with a permanent colostomy after curative surgery for rectal cancer
South Africa
Patients with a permanent colostomy after curative surgery for rectal cancer
Spain
Patients with a permanent colostomy after curative surgery for rectal cancer
Sweden
Patients with a permanent colostomy after curative surgery for rectal cancer
Turkey
Patients with a permanent colostomy after curative surgery for rectal cancer
the United Kingdom
Patients with a permanent colostomy after curative surgery for rectal cancer
Interventions
All patients are asked to answer a panel of questionnaires to test validity and reliability of the Colostomy Impact Score.
Eligibility Criteria
All patients with a permanent colostomy after curative intended surgery for rectal cancer. Time since surgery must be more than 1 year. In some countries the cohort will be extracted from a national or institutional registry representing all operated patients in a certain time period that allows for inclusion of 250 patients. In countries whithout such registries convenient inclusion from the surgical department or stoma clinic.
You may qualify if:
- Curative intended Hartmann's procedure or abdominal perineal excision \>12 months ago for carcinoma of the rectum
- Permanent colostomy
You may not qualify if:
- Age \< 18 years
- Recurrence of cancer
- Mental dementia
- Unable to understand the actual language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Eloy Espin, Department of Surgery, Universidad Autonoma de Barcelonacollaborator
- Kelly Buzatti, Federal University of Minas Geraiscollaborator
- Dong Pang, Peking University School of Nursingcollaborator
- Mansoura Universitycollaborator
- Edgar Furnee, University Medical Center, Groningencollaborator
- Annika Sjövall, Karolinska Institute, Stockholmcollaborator
- Tomas Poskus, Faculty of Medicine, Vilnius Universitycollaborator
- Sheba Medical Centercollaborator
- Andrea Warwick, Redcliffe and QEII Jubilee Hospitalscollaborator
- Nuno Rama,Centro Hospitalar Leiria Pombalcollaborator
Study Sites (1)
Department of Surgery, Aarhus University Hospital
Aarhus, Aarhus C, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helle Ø Kristensen, MD
Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects After Cancer in the Pelvic Organs, Department of Surgery, Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 24, 2018
First Posted
May 7, 2018
Study Start
February 1, 2019
Primary Completion
December 1, 2019
Study Completion
December 31, 2020
Last Updated
November 17, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share